相关实验视频
Updated: Jul 18, 2026

07:29
Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
20.3K
降低PLK2通过Nrf2/HO-1通路在糖尿病小鼠中促进心房动
Huan-Huan Liu1,2, Fan Yang2, Lei Zhang2
1Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, China.
Acta diabetologica
|March 13, 2025
概括
2型糖尿病会损害心房通道的表达,增加AF风险. 这通过PLK2/Nrf2/HO-1通路发生,这种通路被高葡萄糖抑制.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 2型糖尿病 (T2DM) 与较高的心房动 (AF) 发病率有关.
- 连接T2DM和AF的机制,特别是涉及心脏通道,需要进一步阐明.
- 对心房通道 (Kv1.5,Kv4.2,Kv4.3) 的调节失调与AF的发病有关.
研究的目的:
- 在T2DM小鼠模型中研究心房道蛋白Kv1.5,Kv4.2和Kv4.3异常表达背后的机制.
- 探索PLK2/Nrf2/HO-1通路在糖尿病条件下调节这些通道中的作用.
主要方法:
- 使用db/db小鼠作为T2DM模型和对照 littermates.
- 使用乙胆化注射诱导的AF.
- 在高葡萄糖条件下培养HL-1细胞,并用二甲基酸盐 (DMF) 或血红素处理.
- 通过西部涂抹和免疫光学评估蛋白质表达和局部化.
主要成果:
- 高血糖在体内和体外显著降低了Kv1.5,Kv4.2和Kv4.3蛋白质的表达.
- 在糖尿病患者中观察到PLK2,Nrf2,p-Nrf2和HO-1蛋白的下调.
- 高葡萄糖和PLK2敲击损害了Nrf2核转位;PLK2过度表达或DMF/血红素治疗恢复了通道表达.
结论:
- 糖尿病降低了心房Kv1.5,Kv4.2和Kv4.3蛋白质的表达.
- 这种减少是通过抑制PLK2/Nrf2/HO-1通路的介导.
- 通道功能受损有助于增加T2DM的AF易感性.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:

